Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech discloses new brain-penetrant PI3K inhibitors

Sep. 12, 2011

ME-143 enters clinical development

Sep. 9, 2011

Alchemia opens recruitment in phase II HA-irinotecan trial

Sep. 9, 2011

FDA clears DelMar Pharmaceuticals' IND for phase I/II VAL-083 trial

Sep. 9, 2011

Novel recombinant proteins catalyze tRNA aminoacylation

Sep. 9, 2011

Novartis develops novel cyclin-dependent kinase inhibitors

Sep. 9, 2011

Phase I/II data presented on DAC-060 in nonmelanoma skin cancer

Sep. 9, 2011

Safety data presented from clinical evaluation of BIBF-1120 in hepatocellular carcinoma

Sep. 9, 2011

Novartis gains E.U. approval for Votubia

Sep. 8, 2011

Prespecified number of events reached for unblinding of Exelixis' EXAM trial

Sep. 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...